Anxiety and Paranasal sinus hypersecretion
Paranasal sinus hypersecretion is found among people with Anxiety, especially for people who are female, 60+ old.
The study analyzes which people have Paranasal sinus hypersecretion with Anxiety. It is created by eHealthMe based on reports of 61 people who have Anxiety from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
61 people who have Anxiety and Paranasal Sinus Hypersecretion are studied.
What is Anxiety?
Anxiety is found to be associated with 4,649 drugs and 4,947 conditions by eHealthMe.
What is Paranasal sinus hypersecretion?
Paranasal sinus hypersecretion is found to be associated with 645 drugs and 366 conditions by eHealthMe.
Number of Paranasal sinus hypersecretion in Anxiety reports submitted per year:
Gender of people who have Anxiety and experienced Paranasal Sinus Hypersecretion *:
- female: 88.52 %
- male: 11.48 %
Age of people who have Anxiety and experienced Paranasal Sinus Hypersecretion *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 1.96 %
- 20-29: 3.92 %
- 30-39: 7.84 %
- 40-49: 9.8 %
- 50-59: 31.37 %
- 60+: 45.1 %
Common co-existing conditions for these people *:
- Pain: 23 people, 37.70%
- High Blood Pressure: 19 people, 31.15%
- Depression: 18 people, 29.51%
- High Blood Cholesterol: 17 people, 27.87%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 16 people, 26.23%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 15 people, 24.59%
- Migraine (headache): 9 people, 14.75%
- Insomnia (sleeplessness): 9 people, 14.75%
- Hypersensitivity: 8 people, 13.11%
- Diabetes: 8 people, 13.11%
Common drugs taken by these people *:
- Humira: 27 people, 44.26%
- Xanax: 18 people, 29.51%
- Prilosec: 9 people, 14.75%
- Glipizide: 8 people, 13.11%
- Cymbalta: 8 people, 13.11%
- Spiriva: 7 people, 11.48%
- Metformin: 7 people, 11.48%
- Prednisone: 7 people, 11.48%
- Lipitor: 6 people, 9.84%
- Lisinopril: 6 people, 9.84%
Common symptoms for these people *:
- Cough: 23 people, 37.70%
- Nausea (feeling of having an urge to vomit): 15 people, 24.59%
- Fatigue (feeling of tiredness): 12 people, 19.67%
- Chest Pain: 11 people, 18.03%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 11 people, 18.03%
- Headache (pain in head): 11 people, 18.03%
- Fever: 10 people, 16.39%
- Nasopharyngitis (inflammation of the nasopharynx): 8 people, 13.11%
- Fall: 8 people, 13.11%
- Joint Pain: 8 people, 13.11%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Paranasal sinus hypersecretion?Check whether Paranasal sinus hypersecretion is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Treatments, associated drugs and conditions:
COVID vaccines that are related to Paranasal sinus hypersecretion:
- Paranasal sinus hypersecretion in Moderna COVID Vaccine
- Paranasal sinus hypersecretion in Pfizer BioNTech Covid Vaccine
- Paranasal sinus hypersecretion in Johnson and Johnson Covid Vaccine
Common drugs associated with Paranasal sinus hypersecretion:
All the drugs that are associated with Paranasal sinus hypersecretion:
- Paranasal sinus hypersecretion (645 drugs)
Common conditions associated with Paranasal sinus hypersecretion:
All the conditions that are associated with Paranasal sinus hypersecretion:
- Paranasal sinus hypersecretion (366 conditions)
How the study uses the data?
The study is based on Paranasal sinus hypersecretion and Anxiety, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Humira and Heart Valve Calcification - 2 seconds ago
- Gemzar and General Physical Condition Abnormal - 2 seconds ago
- Morphine Sulfate and Hypertensive Heart Disease - 3 seconds ago
- Precose and Muscle Atrophy - 6 seconds ago
- How effective is Cozaar for Blood Pressure Management? - 8 seconds ago